gamma-Tocotrienol (gamma-T3), a naturally occurring analog of tocopherol (v
itamin E), has been shown to have a hypocholesterolemic effect in animals a
nd humans. Unlike tocopherol, it has also been shown to reduce plasma apoB
levels in hypercholesterolemic subjects. The aim of this study was to defin
e the mechanism of action of gamma-T3 on hepatic modulation of apoB product
ion using cultured HepG2 cells as the model system. HepG2 cells preincubate
d with gamma-T3 were initially shown to inhibit the rate of incorporation o
f [C-14]acetate into cholesterol in a concentration- and time-dependent man
ner, with a maximum 86 +/- 3% inhibition at 50 mu mol/L observed within 6 h
ours. gamma-T3, on the other hand, had no significant effect on the uptake
of [C-14]glycerol into pools of cellular triacylglycerol and phospholipid r
elative to untreated control. The rate of apoB synthesis and secretion was
then studied by an [S-35]methionine pulse-labeling experiment and quantifie
d by immunoprecipitating apoB on chasing up to 3 hours. An average reductio
n of 24 +/- 3% in labeled apoB in the media was apparent with gamma-T3 desp
ite a 60 +/- 2% increase in apoB synthesis. Fractionation of secreted apoB
revealed a relatively denser lipoprotein particle, suggesting a less stable
particle. Using a digitonin-permeabilized HepG2 cell system, the effects o
f gamma-T3 on apoB translocation and degradation in the endoplasmic reticul
um were further investigated. The generation of a specific N-terminal 70-kD
a proteolytic fragment proved to be a sensitive measure of the rate of apoB
translocation and degradation The abundance of this fragment increased sig
nificantly in gamma-T3-treated cells relative to untreated control cells (5
0 +/- 21%) after 2 hours of chase. In addition, the presence of gamma-T3 re
sulted in an average decrease of 64 +/- 8% in intact apoB. Taken together,
the data suggest that gamma-T3 stimulates apoB degradation possibly as the
result of decreased apoB translocation into the endoplasmic reticulum lumen
. It is speculated that the lack of cholesterol availability reduces the nu
mber of secreted apoB-containing lipoprotein particles by limiting transloc
ation of apoB into the endoplasmic reticulum lumen.